Feasibility of Endoscopic Thyroidectomy for Thyroid Carcinoma

Brief Title

Feasibility of Endoscopic Thyroidectomy for Thyroid Carcinoma

Official Title

Comparison of Effectiveness and Safety of Thyroidectomy for Thyroid Carcinoma in Patients Undergo Endoscopic Surgery and Those Receive Conversion

Brief Summary

      Endoscopic thyroidectomy has been used to treat thyroid diseases in China. However, whether
      this technique is rational to treat thyroid carcinoma is still in controversy. The diagnosis
      of thyroid carcinoma is predominantly made according to intra-operative frozen section
      pathological examination in China. In this research, the investigators want to compare
      clinical index (blood loss, operation duration, number of lymph nodes dissected, complication
      rates, etc) between patients underwent endoscopic thyroidectomy ( total thyroidectomy) and
      those underwent conversion to open procedure. The investigators want to evaluate the
      technical feasibility of endoscopic thyroidectomy for treating thyroid carcinoma.
    

Detailed Description

      intra-operative diagnosis of thyroid carcinoma is usually considered the indication of
      conversion to open surgery. with accumulation of experience of endoscopic thyroidectomy, the
      investigators want to evaluate the technical feasibility, completeness and safety of
      endoscopic thyroidectomy.
    

Study Type

Interventional

Primary Outcome

to evaluate the completeness of thyroid resection and clearance of lymph nodes in the central compartment, and to observe the complications such as RLN palsy and hypocalcemia

Condition

Thyroid Carcinoma

Intervention

thyroidectomy

Study Arms / Comparison Groups

 conversion

Description:  

Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Status

Procedure

Estimated Enrollment

60

Start Date

January 2010

Completion Date

June 2012

Primary Completion Date

December 2011

Eligibility Criteria

        Inclusion Criteria:

          -  lesion diameter less than 1 cm by ultrasound

        Exclusion Criteria:

          -  frozen section diagnosis indicates benign lesion
      

Gender

All

Ages

18 Years - 45 Years

Accepts Healthy Volunteers

No

Contacts

Ming QIU, Dr., 8621-81885801, [email protected]

Location Countries

China

Location Countries

China

NCT ID

NCT00993837

Organization ID

SMMU-2-2009-3

Study Sponsor

Second Military Medical University

Study Sponsor

Ming QIU, Dr., Study Chair, Changzheng Hospital affliated to SMMU

Verification Date

October 2009